NEW YORK, March 30, 2015 (GLOBE NEWSWIRE) -- Maxim Group LLC, a leading full-service investment banking, securities and wealth management firm announced the expansion of its Healthcare Equity Research platform through the promotions of Dr. Jason McCarthy, Ph.D and Robert LeBoyer.
Jason McCarthy will serve as an Equity Research Analyst covering the biotechnology sector with a focus on the infectious disease and monoclonal antibody spaces. Prior to joining Maxim Group, Dr. McCarthy received his doctoral degree in Biomedical Research (Albert Einstein College of Medicine) and Molecular Biology (Adelphi University), as well as a B.S. in Biochemistry from Stonybrook University.
Robert LeBoyer will also serve as an Equity Research Analyst covering the biotechnology and specialty pharmaceutical sectors. Prior to joining Maxim Group, Mr. LeBoyer served as an investment banker at Aurora Capital and was the acting CFO of a private biotechnology company. He began his research career at Prudential Securities, and has been a Senior Biotechnology Analyst at Brown Brothers Harriman and Leerink Swann. Mr. LeBoyer holds a B.A. in Economics from Tulane University and an M.B.A. from Columbia Business School.
"As we continue to expand the healthcare vertical at Maxim Group, we are confident that Jason and Robert's diverse backgrounds and experiences will enable them to make significant contributions to the Maxim Group Healthcare Team led by Jason Kolbert," said Anthony V. Vendetti, Executive Managing Director and Head of Equity Research for Maxim Group. The Healthcare platform consists of five analysts, which is supported by a specialized research sales team focused on creating value in this paradigm-shifting industry.
About Maxim Group LLC
Maxim Group LLC is a leading full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed income and derivative sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA), Securities Insurance Protection Corporation (SIPC), NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com.